NYSE: DNA - Ginkgo Bioworks Holdings, Inc.

Yield per half year: -37.57%
Sector: Healthcare

Share chart Ginkgo Bioworks Holdings, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Ginkgo Bioworks Holdings, Inc. разрабатывает платформу для клеточного программирования. Его платформа используется для программирования клеток для обеспечения биологического производства продуктов, таких как новые терапевтические препараты, пищевые ингредиенты и химические вещества, полученные из нефти. Компания обслуживает различные конечные рынки, включая специализированные химические продукты, сельское хозяйство, продукты питания, потребительские товары и фармацевтику. Ginkgo Bioworks Holdings, Inc. была основана в 2008 году и базируется в Бостоне, штат Массачусетс.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-04-19
ISIN US37611X1000
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.ginkgobioworks.com
Цена ао 8.74
Change price per day: -10.63% (9.78)
Change price per week: -24.98% (11.65)
Change price per month: -15.39% (10.33)
Change price per 3 month: +20.05% (7.28)
Change price per half year: -37.57% (14)
Change price per year: -83.19% (52)
Change price per 3 year: +91.67% (4.56)
Change price per 5 year: 0% (8.74)
Change price per 10 year: 0% (8.74)
Change price per year to date: -13.29% (10.08)
All parameters

Underestimation

Title Value Grade
P/S 0.3383 10
P/BV 0.0775 10
P/E 0 0
EV/EBITDA 1.04 10
Total: 6

Efficiency

Title Value Grade
ROA, % -53.61 0
ROE, % -81.38 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4025 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 365.66 10
Yield Ebitda, % 670.02 10
Yield EPS, % 22859.78 10
Total: 10
More

Institutions Volume Share, %
Baillie Gifford and Company 233 13.63
ARK Investment Management, LLC 190 11.09
Viking Global Investors, L.P. 143 8.37
Vanguard Group Inc 126 7.36
Blackrock Inc. 73 4.26
Anchorage Capital Group, LLC 70 4.09
Sumitomo Mitsui Trust Holdings, Inc. 56 3.27
Nikko Asset Management Americas, Inc. 56 3.27
Morgan Stanley 49 2.87
State Street Corporation 27 1.56

ETF Share, % Profitability for 1 year, % Dividends, %
De-Spac ETF 5.53 0 0.09
AXS Cannabis ETF 1.2 1.95 2.89
iShares Morningstar Small-Cap Growth ETF 0.00801 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.00801 590.83 0.72598
iShares Morningstar Small-Cap ETF 0.00654 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00654 391.25 1.60498
iShares Morningstar Small Cap Value ETF 0.00562 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.00562 199.14 2.50476
iShares U.S. Tech Breakthrough Multisector ETF 0.00511 24.34 0.73986
Vanguard ESG U.S. Stock ETF 0 23.74 1.26927



Head Job title Payment Year of birth
Dr. Jason Kelly Founder, CEO & Director 262.5k 1981 (44 years)
Dr. Reshma P. Shetty Founder, President, COO & Director 262.5k 1981 (44 years)
Mr. Mark E. Dmytruk Chief Financial Officer 465.25k 1971 (54 years)
Mr. Bartholomew Canton Founder, CTO & Secretary N/A
Ms. Samantha Sutton Head of People N/A
Mr. Thomas Knight Jr. Founder N/A
Karen Tepichin General Counsel & Secretary N/A
Mr. Steven P. Coen CPA Chief Accounting Officer N/A
Mr. Austin Che Ph.D. Founder, Head of Strategy & Treasurer
Ms. Anna Marie Wagner M.B.A. Senior Vice President of Corporate Development 1990 (35 years)

Address: United States, Boston, MA , 27 Drydock Avenue - open in Google maps, open in Yandex maps
Website: https://www.ginkgobioworks.com